New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
November 3, 2009
06:36 EDT
ANDS
theflyonthewall.com:
Anadys Pharma upgraded to Overweight from Neutral at Piper Jaffray
Piper upgraded Anadys Pharmaceuticals ahead of the data for the company's HCV polymerase inhibitor. Target $2.50.
:theflyonthewall.com
News For ANDS From The Last 14 Days
Check below for free stories on ANDS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for these search parameters.
